Response to Biologic Disease-Modifying Anti-Rheumatic Drugs after Discontinuation of Anti-Tumor Necrosis Factor Alpha Agents for Rheumatoid Arthritis

INTRODUCTION: The aim of this study was to compare the response between subsequent use of anti-tumor necrosis factor α (anti-TNF) agents and biologic disease-modifying anti-rheumatic drugs (bDMARD) with other mechanism of action (MOA) in rheumatoid arthritis (RA) patients with history of anti-TNF tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergman, Martin J., Elkin, Eric P., Ogale, Sarika, Kamath, Tripthi, Hamburger, Max I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883258/
https://www.ncbi.nlm.nih.gov/pubmed/27747760
http://dx.doi.org/10.1007/s40744-014-0002-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883258/
https://www.ncbi.nlm.nih.gov/pubmed/27747760
http://dx.doi.org/10.1007/s40744-014-0002-7

Ejemplares similares